Sanofi India Ltd

Sanofi India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi India Ltd

₹ 6,054 -0.37%
22 Nov - close price
sanofiindialtd.com BSE: 500674 NSE: SANOFI
About

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]

Key Points

Parent Company[1]
Sanofi Global and its 100% subsidiary - Hoechst GmbH, are the shareholders of Sanofi India and together hold 60.40%. Company's follows parent company's financial year hence, Financial year is same as Calender Year.

Website BSE NSE
  • Market Cap ₹ 13,932 Cr.
  • Current Price ₹ 6,054
  • High / Low ₹ 7,600 / 4,606
  • Stock P/E 33.0
  • Book Value ₹ 298
  • Dividend Yield 2.76 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 20.3 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Part of BSE Healthcare Nifty Smallcap 250 BSE Allcap BSE SmallCap Nifty MidSmallcap 400

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
515 491 694 511 464 524
393 377 506 374 348 404
Operating Profit 122 114 187 137 116 120
OPM % 24% 23% 27% 27% 25% 23%
57 82 12 41 21 2
Interest 1 0 0 0 0 0
Depreciation 9 9 10 9 9 9
Profit before tax 169 186 189 169 127 113
Tax % 27% 18% 27% 19% 19% 27%
123 152 138 137 103 82
EPS in Rs 53.43 66.04 59.87 59.39 44.87 35.74
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 TTM
2,851 2,192
2,044 1,632
Operating Profit 807 560
OPM % 28% 26%
79 76
Interest 2 2
Depreciation 40 37
Profit before tax 846 598
Tax % 29%
603 460
EPS in Rs 262.13 199.87
Dividend Payout % 64%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: 10%
5 Years: 8%
3 Years: 7%
1 Year: 24%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Jun 2024
Equity Capital 23 23
Reserves 992 662
19 22
681 654
Total Liabilities 1,715 1,360
315 302
CWIP 16 29
Investments 0 0
1,384 1,029
Total Assets 1,715 1,360

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023
230
38
-878
Net Cash Flow -610

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023
Debtor Days 17
Inventory Days 202
Days Payable 89
Cash Conversion Cycle 130
Working Capital Days 25
ROCE %

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%
9.22% 8.99% 8.71% 8.26% 6.99% 6.71% 6.72% 6.80% 6.31% 6.11% 5.81% 5.78%
19.05% 18.65% 18.59% 18.28% 19.22% 19.46% 19.65% 21.68% 22.51% 22.88% 22.60% 22.62%
11.33% 11.96% 12.30% 13.08% 13.41% 13.43% 13.22% 11.10% 10.78% 10.61% 11.21% 11.20%
No. of Shareholders 50,91659,27664,54273,73474,59376,69471,51368,59862,87061,84967,66266,211

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls